Pharmacotherapy for overweight/obesity in ethnic minorities and White Caucasians: a systematic review and meta‐analysis
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Ethnic minorities in the West exhibit a higher prevalence of obesity and also under‐achieve in weight management compared to White Caucasians. A systematic review of randomized controlled trials (RCTs) in adults (mean age ≥18 years, duration ≥6 months and published in the English language) was undertaken to evaluate the effectiveness of antiobesity drugs in ethnic minorities and White Caucasians. Data sources between 1990 and 2010 were searched including MEDLINE, EMBASE, Cochrane Controlled Trials Register, CINAHL and references cited in the included studies of other reviews. Eighteen RCTs that met the inclusion criteria were included in this review (6 sibutramine and 12 orlistat). A random effects model was used for meta‐analysis. An indirect comparison of weight loss in sibutramine‐treated patients in ethnic minorities was significantly lower than in White Caucasians: −2.7 kg (95% CI: −3.1 to −2.3) versus −4.4 kg (95% CI: −5.0 to −3.8), respectively. For orlistat, weight loss was similar in the two groups: −2.3 kg (95% CI: −2.6 to −2.0) in ethnic minorities and −2.8 kg (95% CI: −5.1 to −0.5) in White Caucasian participants. Overall, there were few studies of weight loss pharmacotherapy for comparison of this review and it was not possible to analyse data based on ethnic groupings. More ethnically tailored studies are needed to assess the most effective weight loss strategies in these most metabolically vulnerable groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 3×
“Study Population Mean age (years) Mean BMI (kg/m2) Intervention versus control Attrition percentage (treatment/control) McMahon [34] White Caucasians (n = 180) and ethnic minority (Black and Mexican American) (n = 50) hypertensive patients 51.1 34.0 Sibutramine 20 mg once daily (n = 146) + dietary advice versus placeb…”
BackgroundInfluentialLong term pharmacotherapy for obesity and overweight: updated meta-analysis
Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. W. (2007) · BMJ · doi:10.1136/bmj.39385.413113.25 · Cited by 801
Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Phelan, S., Cato, R. K., Hesson, L. A., Osei, S. Y., Kaplan, R., & Stunkard, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050156 · Cited by 794
Douketis, J. D., Macie, C., Thabane, L., & Williamson, D. F. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802982 · Cited by 665 · cited 1×
“These inclusion criteria were used because it was thought the 6-month duration is the period within which the effectiveness of a weight management intervention should be evaluated [24].”
MethodHollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Harrison, S. A., Fecht, W., Brunt, E. M., & Neuschwander‐Tetri, B. A. (2009) · Hepatology · doi:10.1002/hep.22575 · Cited by 470 · cited 3×
“Harrison [50] White Caucasians (n = 28) and ethnic minority (Blacks, non-White Hispanics and Asians) (n = 13) patients with non-alcoholic steatohepatitis 47.”
BackgroundInfluentialWeight-related attitudes and behaviors of black women
Kumanyika, S., Wilson, J. F., & Guilford-Davenport, M. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)92287-8 · Cited by 378
Orlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
Padwal, R., Li, S. K., & Lau, D. C. W. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802475 · Cited by 348
Cited by
Contemporary medical, device, and surgical therapies for obesity in adults
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02403-5 · Cited by 738
Disparities in Access and Quality of Obesity Care
Washington, T. B., Johnson, V. R., Kendrick, K., Ibrahim, A. A., Tu, L., Sun, K., & Stanford, F. C. (2023) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2023.02.003 · Cited by 141
Epidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26
Newsome, F. A., Gravlee, C. C., & Cardel, M. I. (2021) · Nursing Clinics of North America · doi:10.1016/j.cnur.2021.07.003 · Cited by 18
Metadata
- Authors
- Osei‐Assibey, G., Adi, Y., Kyrou, I., Kumar, S., & Matyka, K.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2011-03-24
- Volume
- 13
- Issue
- 5
- Pages
- 385-393
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2109462977
- Cited by
- 18
- References
- 15
- FWCI
- 0.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy for overweight/obesity in ethnic minorities and White Caucasians: a systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/j.1463-1326.2010.01346.x
- The paper
- Osei‐Assibey, G., Adi, Y., Kyrou, I., Kumar, S., & Matyka, K. (2011). Pharmacotherapy for overweight/obesity in ethnic minorities and White Caucasians: a systematic review and meta‐analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2010.01346.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.